Upgrade to SI Premium - Free Trial

Edwards Lifesciences (EW) PT Lowered to $76 at Truist Securities

October 26, 2023 5:07 AM
Truist Securities analyst Richard Newitter lowered the price target on Edwards Lifesciences (NYSE: EW) to $76.00 (from $83.00) while maintaining a Buy rating.

Categories

Analyst PT Change

Next Articles